ribociclib has been researched along with Vitiligo* in 1 studies
1 other study(ies) available for ribociclib and Vitiligo
| Article | Year |
|---|---|
Ribociclib-induced extensive vitiligo-like lesions: possible pathomechanisms with clinical, dermoscopic and histological correlation.
Cyclin dependent kinase (CDK) 4/6 inhibitors are targeted agents which act on cyclin-D and these combined with hormonal therapy have been approved for the treatment of locally advanced or metastatic breast cancer. CDK 4/6 inhibitors have been found to have a tolerable adverse event profile; however, they have been associated with various dermatological adverse events. We report a case of ribociclib-induced vitiligo and discuss the clinical, dermoscopic and histological features with a review of the various possible pathomechanisms involved. Topics: Aminopyridines; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Humans; Protein Kinase Inhibitors; Purines; Vitiligo | 2022 |